n-acetylneuraminic acid and Erythroblastosis Fetalis

n-acetylneuraminic acid has been researched along with Erythroblastosis Fetalis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Abrahams, JL; Armour, KL; Ederveen, AH; Kapur, R; Koeleman, CAM; Kumpel, BM; Olovnikova, NI; Rudd, PM; Saldova, R; Vidarsson, G; Wuhrer, M	1

Other Studies

1 other study(ies) available for n-acetylneuraminic acid and Erythroblastosis Fetalis

Article	Year
Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy. Scientific reports, 2020, 01-30, Volume: 10, Issue:1 Topics: Animals; Antibodies, Monoclonal; Cell Line; Cricetulus; Erythroblastosis, Fetal; Fucose; Galactose; Glycosylation; Humans; Hybridomas; Immunoglobulin G; Mice; N-Acetylneuraminic Acid; Rats; Rho(D) Immune Globulin; Treatment Outcome	2020

Article

Year

Anti-D monoclonal antibodies from 23 human and rodent cell lines display diverse IgG Fc-glycosylation profiles that determine their clinical efficacy.

Scientific reports, 2020, 01-30, Volume: 10, Issue:1

Topics: Animals; Antibodies, Monoclonal; Cell Line; Cricetulus; Erythroblastosis, Fetal; Fucose; Galactose; Glycosylation; Humans; Hybridomas; Immunoglobulin G; Mice; N-Acetylneuraminic Acid; Rats; Rho(D) Immune Globulin; Treatment Outcome

2020